Literature DB >> 10225220

Citalopram treatment of traumatic brain damage in a 6-year-old boy.

G Andersen1, M Stylsvig, N Sunde.   

Abstract

Traumatic brain damage may cause acute emotional symptoms such as uncontrolled crying, apathy, and sleep problems. Rehabilitation may be less effective in patients afflicted by these symptoms. Citalopram, a selective serotonin reuptake inhibitor (SSRI), has a documented immediate and dramatic effect on pathological crying in stroke patients. The present case history of a 6-year-old boy with a traumatic right-sided hemorrhage in the basal ganglia indicates that early SSRI treatment has a dramatic effect on pathological crying and in addition may have a concomitant beneficial effect on motor paresis, sleep disturbance, and neurobehavioral problems.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10225220     DOI: 10.1089/neu.1999.16.341

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  5 in total

1.  Abnormal pontine activation in pathological laughing as shown by functional magnetic resonance imaging.

Authors:  H Kosaka; N Omata; M Omori; T Shimoyama; T Murata; K Kashikura; T Takahashi; J Murayama; Y Yonekura; Y Wada
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12       Impact factor: 10.154

Review 2.  Pathological laughing and crying : epidemiology, pathophysiology and treatment.

Authors:  Hal S Wortzel; Timothy J Oster; C Alan Anderson; David B Arciniegas
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 3.  Current concepts in the pharmacotherapy of pseudobulbar affect.

Authors:  Erik P Pioro
Journal:  Drugs       Date:  2011-06-18       Impact factor: 9.546

Review 4.  Common psychiatric syndromes and pharmacologic treatments of traumatic brain injury.

Authors:  L A Labbate; D L Warden
Journal:  Curr Psychiatry Rep       Date:  2000-06       Impact factor: 5.285

5.  Traumatic basal ganglia hematoma following closed head injuries in children.

Authors:  Ahmet Öğrenci; Murat Şakir Ekşi; Barış Gün; Orkun Koban
Journal:  Childs Nerv Syst       Date:  2016-03-18       Impact factor: 1.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.